Solid Tumours
LOXO-FG3
An Open-Label, Multicenter Study of LOXO-435 (LY3866288) in Advanced Solid Tumour Malignancies with FGFR3 Alterations.
Trial overview
Clinical Area
Medical Oncology
Disease / Condition
Solid tumours
Study Phase
III
Trial registration
Number: NCT05614739
GenesisCare Location(s)
Principal Investigator(s)